Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Hair Loss With GLP-1 Drugs Is Rare, but Real, Studies Find

The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, ⁠new studies suggest.

Anifrolumab Shows Promise in Refractory Dermatomyositis

Anifrolumab rapidly improves skin disease in refractory dermatomyositis and supports steroid tapering, a study shows.

US Tests GMO Flies in Rush to Fight Flesh-eating Livestock Pest

At a U.S.-funded facility in Panama, scientists are preparing to launch the first outdoor tests of genetically modified screwworm flies, a milestone in efforts to develop a...

Guideline: How To Adjust Cancer Tx in Derm Surgery Patients

A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing resection for a concomitant dermatologic malignancy.

Measles Collaborative Aims to Provide Updated Guidance

With lack of public outreach from federal health authorities, infectious disease experts and medical societies are stepping up.

Intentional Outdoor Tanning Common Among US Adults

Nearly one third of US adults report intentional outdoor tanning in a national survey, a practice that raises the risk for sunburn.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Todays Updates

Glioma Outcomes Shaped by Subtype More Than Tx Sequence

In high-risk low-grade glioma, starting with temozolomide or radiotherapy yields similar survival.

Stem Cell Transplant Associated With Better PFS in NKTCL

Researchers aim to evaluate the effectiveness of ASCT as consolidation therapy for patients with advanced-stage natural killer/T-cell lymphoma who have attained their first complete remission.

Latest News

The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, ⁠new studies suggest.

Anifrolumab rapidly improves skin disease in refractory dermatomyositis and supports steroid tapering, a study shows.

At a U.S.-funded facility in Panama, scientists are preparing to launch the first outdoor tests of genetically modified screwworm flies, a milestone in efforts to develop a...

A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing resection for a concomitant dermatologic malignancy.

With lack of public outreach from federal health authorities, infectious disease experts and medical societies are stepping up.

Nearly one third of US adults report intentional outdoor tanning in a national survey, a practice that raises the risk for sunburn.

News All Time

Nonablative Fractional Laser May Remodel Skin’s Epigenome

Treatment with a 1940-nm nonablative fractional laser may modulate biological pathways linked to both skin aging and skin cancer, a new split-face study suggests.

Vitamin D Improves Cancer Treatment-Related Skin Toxicity

High-dose oral vitamin D is linked to rapid improvement in chemotherapy- and radiation-related toxic effects of the skin.

Black Patients With Cancer Gain Most From Symptom Tracking

Researchers conduct an analysis of a trial to see whether the effects of electronic symptom monitoring varied by race, age, sex, and educational attainment.

SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Scotland approves tebentafusp for metastatic uveal melanoma, a rare eye cancer with a median survival of around 12 months.

Returned Travelers: Could More Than Souvenirs Come Home?

Fever, diarrhea, rash, or jaundice after international travel may indicate an imported infection. Early evaluation and detailed travel history can prevent missed diagnoses.

Can Children Stop Psoriasis Treatment After Remission?

Treatment discontinuation appears to be feasible in children with moderate-to-severe psoriasis for at least 6 months after treatment discontinuation during remission, a study finds.

Panel Provides Consensus for Standardizing CSCC Imaging

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.

Unapproved Peptides Common in Australia Despite Crackdown

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

FPT Plus Pulsed Dye Laser Effective for Port-Wine Birthmarks

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Skin Cancer: 5 Practical Tips for Earlier Detection

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

Dermatology AI Is Here. Now Comes the Hard Part

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Tumor Biomarker Improves Surveillance of MCC Recurrences

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Candida auris Infections Persist, CDC Report Shows

Clinical and screening cases of C auris doubled between 2022 and 2024.

Patient Engagement With Dermatology Visit Notes Remains Low

Patient engagement with dermatology notes in the electronic patient portal varies by language, race, ethnicity, and clinician factors, study shows.

The Newest Frontier for GLP-1s: Clearing Skin Disease

Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly.

Strange Asymptomatic Rash Affects Young Man With Obesity for 2 Years

Diagnosis implicates high triglycerides as a contributor

Recommended News For You

Belzutifan Plus Pembro Approved for Adjuvant RCC

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

When it comes to obesity-related cancers, where you shop for food matters

Recommended Articles For You

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression 

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know 

The Impact of Microadenoma on Hormonal Health 

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study sheds light on challenges for women of color after breast cancer surgery

2.

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

3.

Making informed decisions and managing regret after prostate cancer treatment

4.

What Comes After Cancer?

5.

Q&A: When will individuals be able to receive customized cancer vaccines?

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

3.

Exploring The Causes and Consequences of Low Transferrin Saturation

4.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

5.

Erythropoietic Activity Biomarkers in Functional Hematology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part I

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Thromboprophylaxis In Medical Settings

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot